TOCILIZUMAB IN METHOTREXATE-INTOLERANT OR CONTRAINDICATED PATIENTS-A COST-UTILITY MODEL FOR THE UNITED KINGDOM Dave Harland, Carl Gibbons, Hok Pang,Catherine Huertas,Alex Diamantopoulos,Fred DejonckheereRHEUMATOLOGY(2013)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要